Tuesday, November 24, 2009, 5:09AM AEST - The Australian Stockmarket opens in 4 hours and 51 minutes.
To create a watchlist or portfolio of shares, Register

Neurocrine Biosciences Inc. (NBIX)

4:52AM AEST: 2.17 USD  Up 0.04 (1.88%)  
 MORE ON NBIX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Neurocrine Biosciences, Inc. (NasdaqNM:NBIX) Delayed quote dataEdit
Last Trade:2.17 USD
Trade Time: 4:52AM AEST
Change:Up 0.04 (1.88%)
Prev Close:2.13
Open:2.20
Bid:2.17 x 500
Ask:2.18 x 5300
1y Target Est:4.50
Day's Range:2.15 - 2.22
52wk Range:2.00 - 4.25
Volume:54,520
Avg Vol (3m):154,250
Market Cap:85.08M
P/E (ttm):N/A
EPS (ttm):-1.85
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add NBIX to Portfolio   Download Data

 HEADLINES 
NEUROCRINE BIOSCIENCES INC Financials
EDGAR Online Financials (Thu, Nov 5)
NEUROCRINE BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Oct 30)
Neurocrine Biosciences, Inc. Q3 2009 Earnings Conference Call
at Seeking Alpha (Fri, Oct 30)
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Thu, Oct 29)
Neurocrine Biosciences Reports Third Quarter 2009 Results
PR Newswire (Thu, Oct 29)
Q3 2009 Neurocrine Biosciences, Inc. Earnings Release - After Market Close
CCBN (Wed, Oct 28)
Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
PR Newswire (Sat, Oct 24)
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Oct 2)
Neurocrine Biosciences Amends Corporate Headquarters Lease
PR Newswire (Fri, Oct 2)
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
PR Newswire (Thu, Sep 17)
More Headlines for NBIX...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.39
EPS Est (in 2 years) (Dec-10) :-0.87
Avg Rec (current)*:2.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Neurocrine Biosciences, Inc. engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices